Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - November 2012


The 4th Membrane Protein Technologies Meeting

28 Nov 2012 - 30 Nov 2012 - San Francisco, CA, USA



Bookmark and Share


The 4th NIH Roadmap meeting to Membrane Protein Structures and Complexes will be held at the San Francisco Westin Hotel in downtown San Francisco on Wednesday November 28th 2012, 8:00 AM through Friday, November 30th, noon. This Meeting will be hosted by the Membrane Protein Expression Center, one of the centers funded by the NIH Common Fund Structural Biology Program, organized by Dr. Robert Stroud, UCSF. 

This series of meetings have been very successful in generating open exchange and sharing of technologies, materials, and ideas focused on targeting membrane protein structure determination. This 4th meeting in the series provides a unique opportunity for all investigators engaged in developing and applying new technologies for structural biology of membrane proteins and complexes to focus on technologies that facilitate membrane protein structure determination, and recent structures of membrane proteins. This meeting will include all investigators supported by the NIH common fund program for structural biology, and invites all PSI member membrane protein groups, and all investigators of membrane protein structure to participate fully.

Presentations and discussions chosen from submitted abstracts will focus on progress as well as overcoming barriers that could transform functional expression of membrane proteins and complexes, and structure determination at atomic resolution. Corporate participation is encouraged for those companies who are actively working on membrane protein targets, and those producing equipment and reagents for membrane protein research. Corporate involvement in abstract submission, presentations or display for the meeting is encouraged.

Industry participation is encouraged for companies who are actively working on membrane protein targets, or producing equipment and reagents for membrane protein research. Meeting sponsorships for industry partners are available.



Further information
Scientific News
Liquid Biopsies: Utilization of Circulating Biomarkers for Minimally Invasive Diagnostics Development
Market Trends in Biofluid-based Liquid Biopsies: Deploying Circulating Biomarkers in the Clinic. Enal Razvi, Ph.D., Managing Director, Select Biosciences, Inc.
Lab-on-a-Chip Offers Promise for TB and Asthma Patients
A device to mix liquids using ultrasonics is the first and most difficult component in a miniaturized system for low-cost analysis of sputum from patients with pulmonary diseases such as tuberculosis and asthma.
Intracellular Microlasers Could Allow Precise Labeling of up to a Trillion Individual Cells
MGH investigators have induced structures incorporated within individual cells to produce laser light at wavelengths that differ based on the size, shape and composition of each microlaser, allowing precise labeling of individual cells.
Real-Time Imaging of Lung Lesions During Surgery
Targeted molecular agents cause lung adenocarcinomas to fluoresce during surgery, according to pilot report.
Watching a Tumour Grow in Real-Time
Researchers from the University of Freiburg have gained new insight into the phases of breast cancer growth.
Protein Related to Long Term Traumatic Brain Injury Complications Discovered
NIH-study shows protein found at higher levels in military members who have suffered multiple TBIs.
Childhood Cancer Cells Drain Immune System’s Batteries
Cancer cells in neuroblastoma contain a molecule that breaks down a key energy source for the body’s immune cells, leaving them too physically drained to fight the disease.
Urine Proteins Point to Early-Stage Pancreatic Cancer
A combination of three proteins found at high levels in urine can accurately detect early-stage pancreatic cancer, researchers at the BCI have shown.
Researcher Discovers Trigger of Deadly Melanoma
New research sheds light on the precise trigger that causes melanoma cancer cells to transform from non-invasive cells to invasive killer agents, pinpointing the precise place in the process where "traveling" cancer turns lethal.
New Vaccine For Chlamydia to Use Synthetic Biology
Prokarium Ltd, a biotechnology company developing transformational oral vaccines, have announced new funding from SynbiCITE, the UK’s Innovation and Knowledge Centre for Synthetic Biology.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
2,400+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
3,700+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FREE!